chrX-47058416-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_014735.5(JADE3):c.1811G>A(p.Arg604His) variant causes a missense change. The variant allele was found at a frequency of 0.0000587 in 1,209,243 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 27 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 10/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000099 ( 0 hom., 4 hem., cov: 22)
Exomes 𝑓: 0.000055 ( 0 hom. 23 hem. )
Consequence
JADE3
NM_014735.5 missense
NM_014735.5 missense
Scores
1
1
12
Clinical Significance
Conservation
PhyloP100: 5.52
Genes affected
JADE3 (HGNC:22982): (jade family PHD finger 3) This gene encodes a member of a family of large proteins containing PHD (plant homeo domain)-type zinc fingers. The encoded protein may be associated in a nuclear complex that functions in histone H4 acetylation. Alternative splicing results in multiple transcript variants encoding the same protein. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.06258154).
BS2
High Hemizygotes in GnomAd4 at 4 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
JADE3 | NM_014735.5 | c.1811G>A | p.Arg604His | missense_variant | 11/11 | ENST00000614628.5 | NP_055550.1 | |
JADE3 | NM_001077445.3 | c.1811G>A | p.Arg604His | missense_variant | 11/11 | NP_001070913.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
JADE3 | ENST00000614628.5 | c.1811G>A | p.Arg604His | missense_variant | 11/11 | 1 | NM_014735.5 | ENSP00000481850.1 | ||
JADE3 | ENST00000611250.4 | c.1811G>A | p.Arg604His | missense_variant | 11/11 | 2 | ENSP00000479377.1 |
Frequencies
GnomAD3 genomes AF: 0.0000989 AC: 11AN: 111216Hom.: 0 Cov.: 22 AF XY: 0.000120 AC XY: 4AN XY: 33398
GnomAD3 genomes
AF:
AC:
11
AN:
111216
Hom.:
Cov.:
22
AF XY:
AC XY:
4
AN XY:
33398
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000547 AC: 10AN: 182851Hom.: 0 AF XY: 0.0000593 AC XY: 4AN XY: 67497
GnomAD3 exomes
AF:
AC:
10
AN:
182851
Hom.:
AF XY:
AC XY:
4
AN XY:
67497
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000546 AC: 60AN: 1097974Hom.: 0 Cov.: 31 AF XY: 0.0000633 AC XY: 23AN XY: 363332
GnomAD4 exome
AF:
AC:
60
AN:
1097974
Hom.:
Cov.:
31
AF XY:
AC XY:
23
AN XY:
363332
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000989 AC: 11AN: 111269Hom.: 0 Cov.: 22 AF XY: 0.000120 AC XY: 4AN XY: 33461
GnomAD4 genome
AF:
AC:
11
AN:
111269
Hom.:
Cov.:
22
AF XY:
AC XY:
4
AN XY:
33461
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.1811G>A (p.R604H) alteration is located in exon 11 (coding exon 10) of the JADE3 gene. This alteration results from a G to A substitution at nucleotide position 1811, causing the arginine (R) at amino acid position 604 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;.
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
MutationTaster
Benign
N;N
PrimateAI
Benign
T
Sift4G
Benign
T;T
Polyphen
P;P
Vest4
MutPred
Loss of MoRF binding (P = 0.0047);Loss of MoRF binding (P = 0.0047);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at